Topic

Michigan

A collection of 518 issues

How to Get Luxturna (voretigene neparvovec-rzyl) Covered by Blue Cross Blue Shield of Michigan: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Luxturna Covered by Blue Cross Blue Shield of Michigan Fastest path to approval: Submit the BCBSM Luxturna MARF with confirmed biallelic RPE65 genetic testing from a CLIA-certified lab, retinal thickness documentation (>100 microns), and complete clinical notes to the specialty pharmacy fax at 1-877-325-5979. If denied,
6 min read

Renewing Isturisa (Osilodrostat) Approval with Aetna (CVS Health) in Michigan: Complete Timeline and Documentation Guide

Quick Answer: Renewing Isturisa (Osilodrostat) with Aetna (CVS Health) in Michigan Start your renewal 60-90 days before expiration. Submit updated clinical documentation including recent 24-hour urine free cortisol levels, morning serum cortisol, and physician notes demonstrating continued medical necessity. Use Michigan's standard prior authorization form and expect a
5 min read

HyperHEP (Hepatitis B Immune Globulin) Approval with UnitedHealthcare in Michigan: Complete Coverage Guide

Answer Box: Getting HyperHEP Covered by UnitedHealthcare in Michigan UnitedHealthcare requires prior authorization for HyperHEP (hepatitis B immune globulin) in Michigan, with step therapy often enforced. To get approved: (1) Document the hepatitis B exposure within 24 hours with CDC-compliant clinical rationale, (2) Submit PA through OptumRx with weight-based dosing
5 min read

How to Get Oxlumo (lumasiran) Covered by UnitedHealthcare in Michigan: Appeals Guide with Forms and Timelines

Quick Answer: Getting Oxlumo Covered by UnitedHealthcare in Michigan Oxlumo (lumasiran) requires prior authorization from UnitedHealthcare for primary hyperoxaluria type 1 (PH1). Your fastest path: Have your nephrologist submit a comprehensive PA request with genetic PH1 confirmation, baseline urinary oxalate levels, and medical necessity documentation through the UnitedHealthcare provider portal.
6 min read